These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9199826)

  • 1. Low plasma factor XII activity in patients with systemic lupus erythematosus and a lupus anticoagulant.
    Matsuda J; Gotoh M
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):255-6. PubMed ID: 9199826
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant cofactors and the kidney.
    Cheng HM
    Nephron; 1998; 78(2):245. PubMed ID: 9496755
    [No Abstract]   [Full Text] [Related]  

  • 6. No increase of beta 2-glycoprotein I levels in patients with antiphospholipid antibodies.
    De Benedetti E; Reber G; Miescher PA; de Moerloose P
    Thromb Haemost; 1992 Nov; 68(5):624. PubMed ID: 1455413
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.
    Jones DW; MacKie IJ; Gallimore MJ; Winter M
    Br J Haematol; 2001 May; 113(2):550-2. PubMed ID: 11380430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital factor XII deficiency and lupus anticoagulant.
    Endo Y
    Intern Med; 1994 Mar; 33(3):188. PubMed ID: 8061401
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.
    Viard JP; Amoura Z; Bach JF
    Am J Med; 1992 Aug; 93(2):181-6. PubMed ID: 1497015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII.
    Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M
    Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired activated protein C-resistance in patients with lupus anticoagulants.
    Ehrenforth S; Radtke KP; Scharrer I
    Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
    [No Abstract]   [Full Text] [Related]  

  • 14. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
    Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to factor XII: a possible predictive marker for recurrent foetal loss.
    Jones DW; Gallimore MJ; Winter M
    Immunobiology; 2003; 207(1):43-6. PubMed ID: 12638902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels.
    Quintarelli C; Ferro D; Valesini G; Basili S; Tassone G; Violi F
    J Hepatol; 1994 Dec; 21(6):1086-91. PubMed ID: 7699232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
    Ichikawa Y; Takamatsu K; Shimizu H; Uchiyama M; Moriuchi J; Takaya M; Kobayashi N; Kawada T; Arimori S
    Lupus; 1992 May; 1(3):145-9. PubMed ID: 1301975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
    Denis-Magdelaine A; Flahault A; Verdy E
    Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Newly developed method by the use of factor Y assay for the detection of the lupus anticoagulant].
    Amagai H; Shizuka R; Hayakawa M; Kojima J; Fukumura Y; Kobayashi N; Kobayashi I
    Rinsho Byori; 1993 Jun; 41(6):713-8. PubMed ID: 8361039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do not forget lupus anticoagulant in the era of antiphospholipid antibodies.
    Stratta P; Canavese C; Ferrero S; Grill A; Borchellini A; Schinco P
    Nephron; 1997; 76(2):233-4. PubMed ID: 9200421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.